CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% gel

CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% by

Drug Labeling and Warnings

CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% by is a Prescription medication manufactured, distributed, or labeled by Sincerus Florida, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Directions for use

Sincerus Florida, LLC. Adverse reactions

Active, inactive

NDC:

72934-1050-2 CLINDAMYCIN PHOSPHATE USP 1% / NIACINAMIDE USP 2% / TAZAROTENE 0.05%. Gel 30gm

INGREDIENTS AND APPEARANCE

CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% 
clindamycin 1% / niacinamide 2% / tazarotene 0.05% gel

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 72934-1050
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS)	TAZAROTENE	0.05 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)	NIACINAMIDE	2 g  in 100 g
CLINDAMYCIN PHOSPHATE (UNII: EH6D7113I8) (CLINDAMYCIN - UNII:3U02EL437C)	CLINDAMYCIN PHOSPHATE	1 g  in 100 g

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72934-1050-2	30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	05/10/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		05/10/2019

Labeler - Sincerus Florida, LLC (080105003)

Establishment
Name	Address	ID/FEI	Business Operations
Sincerus Florida, LLC		080105003	manufacture(72934-1050)